Evidence map›Paper›PMID 24391726›Full record

SynthesisPloS one2013

Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials.

Laura Pasin, Teresa Greco, Paolo Feltracco, Annalisa Vittorio, Caetano Nigro Neto, Luca Cabrini, Giovanni Landoni, Gabriele Finco, Alberto Zangrillo

Erratum issuedOpen access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 7 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 7 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2015
    Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Dexmedetomidine: Current Role in Burn ICU.Translational medicine @ UniSa · 2017
    Article
  18. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2014
    Review
  19. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Laura PasinAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
Teresa GrecoAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
Paolo FeltraccoDepartment of Pharmacology and Anesthesiology, University Hospital of Padua, Padua, Italy.
Annalisa VittorioAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
Caetano Nigro NetoAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
Luca CabriniAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
Giovanni LandoniAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy ; Outcomes Research Consortium, Cleveland, Ohio, United States of America.
Gabriele FincoDepartment of Medical Sciences "M. Aresu", Cagliari University, Cagliari, Italy.
Alberto ZangrilloAnesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
San Raffaele University of Rome · ITOutcomes Research Consortium · USUniversity of Cagliari · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe effect of dexmedetomidine on length of intensive care unit (ICU) stay and time to extubation is still unclear. MATERIALS AND

methodsPertinent studies were independently searched in BioMedCentral, PubMed, Embase, and the Cochrane Central Register of clinical trials (updated February first 2013). Randomized studies (dexmedetomidine versus any comparator) were included if including patients mechanically ventilated in an intensive care unit (ICU). Co-primary endpoints were the length of ICU stay (days) and time to extubation (hours). Secondary endpoint was mortality rate at the longest follow-up available.

resultsThe 27 included manuscripts (28 trials) randomized 3,648 patients (1,870 to dexmedetomidine and 1,778 to control). Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction in length of ICU stay (weighted mean difference (WMD) = -0.79 [-1.17 to -0.40] days, p for effect <0.001) and of time to extubation (WMD = -2.74 [-3.80 to -1.65] hours, p for effect <0.001). Mortality was not different between dexmedetomidine and controls (risk ratio = 1.00 [0.84 to 1.21], p for effect = 0.9). High heterogeneity between included studies was found.

conclusionsThis meta-analysis of randomized controlled studies suggests that dexmedetomidine could help to reduce ICU stay and time to extubation, in critically ill patients even if high heterogeneity between studies might confound the interpretation of these results.

Indexed as

Critical IllnessAirway ExtubationBradycardiaCritical CareDexmedetomidineHumansHypnotics and SedativesHypotensionLength of StayRandomized Controlled Trials as TopicTime FactorsDexmedetomidineHypnotics and Sedatives

Identifiers

PMID24391726
PMCPMC3877008
OpenAlexW1990788267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.